<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2401233158
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        JAZOFEN 400MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        IBUPROFEN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        400
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        12.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jazeera Pharmaceutical Industries (JPI)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jazofen is an anti-inflammatory pain killer. It is used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis (including juvenile rheumatoid arthritis or Still&rsquo;s disease), arthritis of the spine (ankylosing spondylitis), swollen joints, frozen shoulder, bursitis, tendinitis, tenosynovitis, lower back pain, sprains and strains.<br />Jazofen can also be used to treat other painful conditions such as toothache, pain after operations, period pain and headache, including migraine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Jazofen</strong></p><p>Your doctor or healthcare provider should know if:</p><ul><li>you are allergic (hypersensitive) to ibuprofen or any&nbsp; of the other ingredients of Jazofen;</li><li>you have, or have you previously had, a stomach ulcer or other gastric complaint. Do not take Jazofen if you currently have a peptic ulcer (ulcer in your stomach or duodenum) or bleeding in your stomach, or have had two or more episodes of peptic ulcers, stomach bleeding or perforation in the past;</li><li>you have a condition which increases your tendency to bleeding;</li><li>you suffer from asthma or have you ever had an allergic reaction or suffered from wheezing after taking ibuprofen, aspirin or other anti- inflammatory pain killers.</li><li>you suffer from severe heart failure, hepatic failure and renal failure.</li><li>you are more than six months pregnant.</li></ul><p>Take special care with Jazofen</p><p>Your doctor or healthcare provider should know if:</p><ul><li>you are less than six months pregnant or planning to become pregnant, or you are breast-feeding. Jazofen may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems becoming pregnant;</li><li>you suffer from liver or kidney disease;</li><li>you suffer from heart disease. Medicines such as Jazofen may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment. If you have heart problems, previous stroke or think that you might be at risk of these conditions (e.g. if you have high blood pressure, diabetes, high cholesterol or are a smoker) you should discuss your treatment with your doctor or pharmacist;</li><li>you have systemic lupus erythematosus (SLE, some- times known as lupus) or a connective tissue disease (autoimmune diseases affecting connective tissue).</li></ul><p>Taking other medicines, herbal or dietary supplements&nbsp; Please tell your doctor, healthcare provider or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. These medicines may be affected by Jazofen, or may affect how well it works. You may need different amounts of your medicines, or you may need to take different medicines, especially if you are taking:</p><ul><li>diuretics (water tablets);</li><li>cardiac glycosides, such as digoxin, used to treat heart conditions;</li><li>lithium;</li><li>&nbsp;zidovudine (an anti-viral drug);</li><li>&nbsp;steroids (used in the treatment of inflammatory conditions);</li><li>methotrexate (used to treat certain cancers);</li><li>medicines known as immunosuppressants such as ciclosporin and tacrolimus (used to dampen down your immune response);</li><li>medicines known as selective serotonin reuptake inhibitors (SSRIs), used for the treatment of depression;</li><li>antibiotics called quinolones such as ciprofloxacin;</li><li>aminoglycosides (a type of antibiotic);</li><li>mifepristone;</li><li>any other ibuprofen preparations, such as those you can buy without a prescription;</li><li>any other anti-inflammatory pain killer, including aspirin;</li><li>cholestyramine (a drug used to lower cholesterol);</li><li>medicines known as sulphonylureas such as glibenclamide (usedto treat diabetes);</li><li>voriconazole or fluconazole (types of anti-fungal drugs);</li><li>Gingko biloba herbal medicine (there is a chance you may bleed more easily if you are taking this with Jazofen).</li></ul><p>Pregnancy and breast feeding</p><p>Please tell your doctor, healthcare provider or pharmacist if you are pregnant or intend to become pregnant, breast-feeding or plan to breastfeed.</p><p>The use of Jazofen whilst pregnant or breast feeding should be avoided.</p><p>Jazofen should not be used in late (the last three months) of pregnancy and should only be taken in the first six months of pregnancy on the advice of your doctor.</p><p>Please ask your doctor, healthcare provider or pharmacist for advice before taking any medicine.</p><p>Driving and using machines</p><p>Jazofen may make you feel dizzy or drowsy. If the tablets affect you in this way do not drive, operate machinery or&nbsp;do anything that requires you to be alert.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Jazofen exactly as your doctor or healthcare provider has told you. You should check with your doctor, healthcare provider or pharmacist if you are not sure. Take your Jazofen with or after food, with a glass of water.</p><p>Jazofen should be swallowed whole and not chewed, broken, crushed or sucked to help prevent discomfort in the mouth or irritation in the throat.</p><p>The usual doses are:</p><p>Adults: The usual dosage is 600 to 1800 mg spread throughout the day. Your doctor may choose to increase this depending on what you are being treated for, but no more than 2400 mg should be taken in one day.</p><p>Children: The usual daily dosage is 20 mg per kg of bodyweight, given in divided doses. Jazofen should not be taken by children weighing less than 7 kg.</p><p>In cases of severe juvenile arthritis your doctor may increase the dosage up to 40 mg/kg in divided doses.</p><p>If you take more Jazofen than you should</p><p>You should contact a doctor or go to the nearest hospital casualty department immediately taking your tablets with you.</p><p>If you forget to take Jazofen</p><p>Take Jazofen as soon as you remember, unless it is almost time for your next dose. If it is, do not take the missed dose at all. Never double up on a dose to make up for the one you have missed.</p><p>If you have any further questions on the use of this product, ask your doctor, healthcare provider or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Jazofen can cause side effects, although not everybody gets them. You can minimize the risk of side effects by taking the least amount of tablets for the shortest amount of time necessary to control your symptoms.</p><p>If you suffer from any of the following at any time during your treatment stop taking Jazofen and seek immediate medical help:</p><ul><li>severe headache, high temperature, stiffness of the neck or intolerance to light;</li><li>pass blood in your faeces (stools/motions);</li><li>pass black tarry stools;</li><li>vomit any blood or dark particles that look like coffee grounds.</li></ul><p>Tell your doctor and stop taking the tablets if you experience:</p><ul><li>unexplained stomach pain or other abnormal stomach symptoms, indigestion, heartburn, feeling sick and/or vomiting;</li><li>unexplained wheezing, shortness of breath, skin rash, itching or bruising; Jazofen-v1.0 2 04.03.2013</li><li>yellowing of the eyes and/or skin;</li><li>severe sore throat with high fever;</li><li>blurred or disturbed vision or seeing/hearing strange things;</li><li>fluid retention (e.g. swollen ankles).</li></ul><p>Medicines such as Jazofen have been associated with a small increased risk of heart attack (myocardial infarction) or stroke.</p><p>Blood disorders, kidney problems, liver problems or severe skin reactions may occur rarely with ibuprofen. Very rarely Jazofen may cause aseptic meningitis (inflammation of the protective membrane surrounding the brain).</p><p>Other side effects may include headache, hallucinations, dizziness, tingling of hands and feet, ringing in the ears, depression, confusion, difficulty sleeping, anxiety, impaired hearing, diarrhea, constipation, flatulence (wind), unexpected sensitivity of the skin to the sun, tiredness, malaise, mood swings and swelling and irritation inside the nose.</p><p>Jazofen has also been shown to sometimes worsen the symptoms of Crohn&rsquo;s disease or colitis.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, ple r doctor, healthcare provider or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not store above 30&deg;C, store in the original carton.</p><p>Do not use Jazofen after the expiry date which is stated on the label and carton after Exp. Date. The expiry date refers to the last day of that month.</p><p><strong>Shelf life: </strong>36 months</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist on how to dispose of medicines no longer required. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is ibuprofen 200 or 400 mg per tablet.</p><p>The other ingredients are povidone K-30, sodium lauryl sulphate, microcrystalline cellulose, croscarmellose sodium, colloidal silicon dioxide, magnesium sterate, talc, titanium dioxide, polyethylene glycol, hypermellose, simethicone emulsion, erythrocin FD&amp;C red No. 3 and polyacrylate dispersion 30.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Jazofen 200 mg tablets are Round biconvex pink film coated tablets, embossed with ‘JI22’.
Jazofen 400 mg tablets are Round biconvex pink film coated tablets, embossed with ‘JI23’.
Jazofen tablets come blister packs containing 30 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder and Manufacturer</strong><br />Jazeera Pharmaceutical Industries&nbsp;<br />Jiser Heet, after ThirdIndustrial Zone. Riyadh-Saudi Arabia<br />&nbsp;Tel: +966 1 4788034<br />Fax: +966 1 4761097<br />Website: www.jpi.com.sa<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 11/2013; version number V1.0

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">جازوفين هو مسكن للألم و مضاد للالتهابات. فهو يستخدم لتخفيف الألم والالتهابات في حالات مثل التهاب المفاصل، والتهاب المفاصل الروماتويدي (بما في ذلك التهاب المفاصل الرثواني الشبابي أو داء ستيل)، والتهاب المفاصل في العمود الفقري (التهاب الفقار اللاصق)، تورم المفاصل، الكتف المتجمدة، التهاب الجراب، التهاب الأوتار، التهاب غمد الوتر، وآلام أسفل الظهر ، والالتواء والرضوض.</p><p dir="RTL">ويمكن لجازوفين أيضا أن يستخدم لعلاج حالات أخرى من الألم مثل الم الأسنان، والألم بعد العمليات، آلام الدورة الشهرية والصداع، بما في ذلك الصداع النصفي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أ- موانع استعمال جازوفين:</p><p dir="RTL">ينبغي أن يعرف الطبيب أو مقدم الرعاية الصحية ما إذا كان:</p><ul dir="rtl"><li>كنت تعاني من حساسية (الحساسية) لايبوبروفين أو أي من المكونات الأخرى لجازوفين؛</li><li>لديك في الوقت الحالي او في السابق، قرحة في المعدة أو غيرها من شكاوى المعدة. لا تأخذ جازوفين إذا كان لديك حاليا قرحة هضمية (قرحة في المعدة أو الاثنى عشر) أو نزيف في المعدة، أو قد تعرضت لحالتين أو أكثر من نوبات من القرحة الهضمية، نزيف في المعدة أو ثقب في الماضي؛</li><li>&nbsp;كان لديك حالة تزيد من قابليتك للنزف؛</li><li>&nbsp;كنت تعاني من الربو أو هل كان لديك أي وقت مضى رد فعل تحسسي او حاله من العطاس بعد أخذ الإيبوبروفين، والأسبرين أو غيره من مسكنات الألم المضادة للالتهابات.</li><li>&nbsp;كنت تعاني من فشل القلب الحاد، والفشل الكبدي والفشل الكلوي.</li><li>&nbsp;كنتي حاملاُ في الشهر السادس او أكثر.</li></ul><p dir="RTL">ب- الإحتياطات عند الإستعمال:</p><p dir="RTL">ينبغي أن الطبيب أو مقدم الرعاية الصحية معرفة ما إذا كان :</p><ul dir="rtl"><li>اذا كنتي حاملا بأقل من ستة أشهر أو تخططين لتصبحي حاملا، أو كنت ترضعين من الثدي. قد يجعل جازوفين الأمر أكثر صعوبة في أن تصبحي حاملا . يجب عليك إبلاغ الطبيب إذا كنتي تخططين لتصبحي حاملا أو إذا كانت لديك مشاكل الحمل ؛</li><li>&nbsp;كنت تعاني من أمراض الكبد أو الكلى .</li><li>كنت تعاني من أمراض القلب . الأدوية مثل جازوفين قد تترافق مع زيادة خطر الاصابة بالنوبات القلبية الصغيرة ( احتشاء عضلة القلب) أو السكتة الدماغية . هذه الخطورة تكون أكثر احتمالا مع الجرعات العالية والعلاج لفترات طويلة. لا تتجاوز الجرعة الموصى بها أو مدة العلاج . إذا كان لديك مشاكل في القلب ، او سكتة دماغية سابقة أو تعتقد أنك قد تكون معرضا لاصابتك بالخالات السابقة (على سبيل المثال إذا كان لديك ارتفاع ضغط الدم ، ومرض السكري ، وارتفاع الكوليسترول في الدم أو مدخنا) يجب مناقشة العلاج مع طبيبك أو الصيدلي.</li><li>لديك الذئبة الحمامية الجهازية (التي تعرف أحيانا باسم الذئبة( أو أمراض النسيج الضام) &nbsp;أمراض المناعة الذاتية التي تؤثر على النسيج الضام).</li></ul><p dir="RTL">ج- التداخلات الدوائية من اخذ جازوفين مع أي ادوية اخرى او اعشاب او مكملات غذائية:</p><p dir="RTL">يرجى اخبار الطبيب او الصيدلي اذا كنت تستخدم او استخدمت مؤخرا أي ادوية اخرى, بما في ذلك الأدوية التي تم الحصول عليها بدون وصفة طبية.</p><p dir="RTL">قد يؤثر جازوفين على كيفية عمل بعض الأدوية التي تتناولها. كما قد تحتاج الى كميات مختلفة من الأدوية الخاصة بك ، و ربما إلى تناول أدوية مختلفة ، وخاصة إذا كنت تأخذ :</p><ul dir="rtl"><li>مدرات البول ؛</li><li>جليكوسيدات القلب مثل الديجوكسين ، وتستخدم لعلاج أمراض القلب؛</li><li>الليثيوم؛</li><li>زيدوفودين (عقار مضاد للفيروسات)</li><li>&nbsp;المنشطات (المستخدمة في علاج حالات الالتهابات).</li><li>الميثوتريكسيت (التي تستخدم لعلاج أنواع معينة من السرطان).</li><li>الأدوية المعروفة باسم مثبطات المناعة مثل السيكلوسبورين و تاكروليموس (التي تستخدم لتقليل الاستجابة المناعية الخاصة بك).</li><li>الأدوية المعروفة باسم مثبطات امتصاص السيروتونين الانتقائية (اس اس اراي)، وتستخدم لعلاج الاكتئاب.</li><li>المضادات الحيوية الكينولون مثل سيبروفلوكساسين .</li><li>&nbsp;الميفيبريستون .</li><li>أي من المستحضرات المحتويه على ايبوبروفين، مثل تلك التي يمكن شراؤها بدون وصفة طبية.</li><li>أي مسكن للألم و مضاد للالتهابات ، بما في ذلك الأسبرين .</li><li>الكولسترامين (وهو دواء يستخدم لخفض الكولسترول).</li><li>الأدوية المعروفة باسم السلفونيل يوريا مثل غليبينكلاميد (يستخدم لعلاج السكري).</li><li>فوريكونازول أو فلوكونازول (أنواع من العقاقير المضادة للفطريات).</li><li>العشبة الطبية المسماه بالجنكه بيلوبا (هناك قابلية اكبر لحدوث نزيف إذا كنت تأخذها مع جازوفين).</li></ul><p dir="RTL"><strong>د - الحمل والرضاعة</strong></p><p dir="RTL">اسأل الطبيب او الصيدلي للحصول على المشورة قبل اتخاذ أي دواء.</p><p dir="RTL">اخبري طبيبك اذا كنت حاملا او تخططين لتصبحي حاملا. ينبغي تجنب استخدام جازوفين مع النساء الحوامل او المرضعات.</p><p dir="RTL">يجب ان لايستخدم جازوفين في وقت متأخر (الأشهر الثلاثة الأخيرة) من الحمل ويجب فقط أن يؤخذ في الأشهر الستة الأولى من الحمل بناء على نصيحة الطبيب.</p><p dir="RTL">من فضلك اطلب المشورة من طبيبك او مزود الرعاية الصحية أو الصيدلي قبل اتخاذ أي دواء.</p><p dir="RTL">ه - تأثير جازوفين على القيادة واستخدام الآلات</p><p dir="RTL">قد يجعلك جازوفين تشعر بالدوار أو النعاس. إذا كانت هذه الأقراص تؤثر عليك في هذه النحو لا تقم بقيادة السيارة، وتشغيل الآلات أو عمل أي شيء يتطلب منك أن تكون في حالة تأهب.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب اخذ جازوفين بالضبط كما وصفه الطبيب, كما انه يجب ان تتأكد من الطبيب او الصيدلي اذا كنت غير متأكد من كيفية استخدام جازوفين.</p><p dir="RTL">يمكن تناول اقراص جازوفين مع أو بعد الطعام، مع كوب من الماء. ينبغي بلع قرص جازوفين كاملا ولا ينبغي لك القيام بمضغه، او كسره، او طحنه أو مصًه وذلك لتجنب عدم الراحة في الفم أو تهيج الحلق.</p><p dir="RTL"><strong>الجرعات المعتادة هي:</strong></p><ul dir="rtl"><li>البالغين: الجرعة المعتادة هي 600-1800 ملغ موزّعة طوال اليوم.</li></ul><p dir="RTL">قد يقوم طبيبك بالزيادة عن مقدار الجرعة المعتاده وذلك بحسب ما تتطلبه الحالة المرضية لديك، ولكن ينبغي عدم تناول أكثر من 2400 ملغ في اليوم الواحد.</p><ul dir="rtl"><li>الأطفال: الجرعة اليومية المعتادة هي 20 ملغ لكل كيلوغرام من وزن الجسم، تعطى في جرعات مقسمة .</li></ul><p dir="RTL">جازوفين لا ينبغي أن يؤخذ من قبل الأطفال الذين تبلغ اوزانهم أقل من 7 كجم.</p><p dir="RTL">في الحالات الشديدة من التهاب المفاصل الأحداث قد يزيد طبيبك من الجرعة لتصل 40 مغ / كلغ في جرعات مقسمة.</p><p dir="RTL"><strong>أ- الجرعة الزائدة</strong></p><p dir="RTL">اذا اخذت جرعة زائدة كبيرة من جازوفين اتصل بطبيبك للحصول على المشورة الطبية، أو الذهاب إلى أقرب قسم طوارىء في المستشفى على الفور وأخذ الأقراص معك.</p><p dir="RTL"><strong>ب- نسيان تناول جرعة جازوفين</strong></p><p dir="RTL">اذا وجدت نفسك نسيت تناول جرعتك من جازوفين تناولها حال تذكرك لها، الاّ اذا تذكرتها في وقت قريب من تناول&nbsp;الجرعة التالية حينها انتظر حتى وقت تناول الجرعة التالية في وقتها المعتاد.</p><p dir="RTL">لا تأخذ جرعة مضاعفة للتعويض عن الجرعة المنسيه.</p><p dir="RTL">اذا كان لديك أي اسئلة اخرى عن استخدام هذا المنتج اسأل طبيبك او الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية يمكن لهذا الدواء ان يسبب اعراضا جانبية، وان لم تحصل لجميع المرضى، يمكنك التقليل من خطر الآثار الجانبية من خلال اتخاذ أقل قدر من الأقراص لأقصر فترة من الوقت اللازم للسيطرة على الأعراض الخاصة بك.</p><p dir="RTL">إذا كنت تعاني من أي من الأعراض التالية في أي وقت أثناء فترة علاجك بجازوفين عليك التوقف عن تناوله وطلب المساعدة الطبية فورا:</p><ul dir="rtl"><li>صداع شديد، ارتفاع درجة الحرارة، وتصلب في الرقبة أو عدم تحمل الضوء؛</li><li>ظهور الدم في البراز؛</li><li>خروج براز قطراني اسود؛</li><li>التقيؤ دماً أو ظهور اجزاء غامقه تبدو مثل القهوة.</li></ul><p dir="RTL">اخبر الطبيب وتوقف عن تناول الأقراص إذا واجهت:</p><ul dir="rtl"><li>ألم غير مبرر في المعدة أو غيرها من أعراض المعدة غير الطبيعية، وعسر الهضم، الحرقة، الشعور بالغثيان و / أو القيء؛</li><li>الصفير غير المبرر، وضيق في التنفس، والطفح الجلدي، والحكة أو كدمات؛</li><li>اصفرار في العينين و / أو الجلد؛</li><li>التهاب الحلق الشديد مع ارتفاع درجة الحرارة؛</li><li>عدم وضوح الرؤية أو اضطرب أو رؤية / سماع أشياء غريبة؛</li><li>احتباس السوائل (مثل تورم الكاحلين).</li></ul><p dir="RTL">وقد ارتبطت الأدوية مثل جازوفين مع زيادة خطر الإصابة بالنوبات القلبية الصغيرة (احتشاء عضلة القلب) أو السكتة الدماغية.</p><p dir="RTL">اضطرابات الدم ومشاكل الكلى ومشاكل في الكبد أو ردود فعل حادة في الجلد قد تحدث نادرا مع ايبوبروفين.</p><p dir="RTL">من النادر جداً ان يسبب جازوفين التهاب السحايا العقيم (التهاب الغشاء الواقي المحيط بالمخ).</p><p dir="RTL">قد تشمل الآثار الجانبية الأخرى الصداع والهلوسة، والدوخة، ووخز في اليدين والقدمين، ورنين في الآذان، والاكتئاب، والارتباك، صعوبة في النوم، والقلق، وضعف السمع، والإسهال، والإمساك، وانتفاخ البطن (الغازات)، حساسية غير متوقعة في الجلد من الشمس، والتعب، والشعور بالضيق، وتقلب المزاج والتورم والاحمرار داخل الأنف.</p><p dir="RTL">وقد تبين أيضا أن جازوفين قد يفاقم أحيانا من أعراض مرض كرون أو التهاب القولون.</p><p dir="RTL">اذا زادت خطورة احد الأعراض الجانبية المذكورة اعلاه، او اذا تمت ملاحظة عرض جانبي آخر غير مدون في هذه النشرة، الرجاء اخبار الطبيب او الصيدلي عن ذلك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ابقي هذا المستحضر بعيدا عن متناول ايدي ونظر الأطفال.</p><p dir="RTL">يخزن في درجة حرارة لا تتجاوز 30 درجة مئوية.</p><p dir="RTL">لاتستخدم جازوفين بعد تاريخ انتهاء الصلاحية كما هو مدون على العبوة ، تاريخ الإنتهاء يشير الى اليوم الأخير من ذلك الشهر.</p><p dir="RTL"><strong>مدة الصلاحية</strong>: 36 شهراً</p><p dir="RTL">لا ينبغي التخلص من الأدوية عن طريق مياه الصرف الصحي او النفايات المنزلية، اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجتها، هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي على المادة الفعالة: ايبوبروفين، كل قرص مغلف يحتوي على 200 مج او 400 مج من الايبوبروفين.</p><p dir="RTL">المحتويات الأخرى: البوفيدون ك- 30 ، لوريل كبريتات الصوديوم، السليلوز الجريزوفولفين، كروسكارميلوز الصوديوم، ثاني أكسيد السيليكون الغروية، ستيرات المغنيسيوم، التلك، وثاني أكسيد التيتانيوم، البولي ايثيلين جلايكول، هايبرمللوز، مستحلب سيميثيكون &nbsp;، الاريثروسين FD &amp; C &nbsp;الأحمر رقم 3, و بولي أكريليت تشتت 30.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">اقراص جازوفين 200 مج المغلفه : اقراص دائرية محدبة من الجهتين بلون وردي ، منقوشة ب &lsquo; 22&rsquo;JI.</p><p dir="RTL">اقراص جازوفين 400 مج المغلفه : اقراص دائرية محدبة من الجهتين بلون وردي ، منقوشة ب &lsquo; 23&rsquo;JI.</p><p dir="RTL">اقراص جازوفين المغلفة بكلا التركيزين متوفرة في عبوة من 30 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>اسم وعنوان مالك رخصة التسويق والمصنع:</strong></p><p dir="ltr">شركة الجزيرة للصناعات الدوائية<br />الرياض 11666 ، ص.ب: 106229<br />medical@jpi.com.sa : ايميل<br />المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقه على هذه النشرة في نوفمبر 2013, رقم النسخة V1.0
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazofen® 400 mg Tablet (Ibuprofen)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 400 mg Ibuprofen.
For a full list of excipients (see section 6.1. List of excipients).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Round biconvex pink film coated tablets, embossed with ‘JI23’.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Jazofen is indicated for its analgesic and anti-inflammatory effects in the treatment of rheumatoid &nbsp; arthritis &nbsp; (including &nbsp; juvenile &nbsp; rheumatoid &nbsp; arthritis &nbsp; or &nbsp; Still&#39;s &nbsp; disease),&nbsp; ankylosing &nbsp; &nbsp;spondylitis, &nbsp; &nbsp;osteoarthritis &nbsp; &nbsp;and &nbsp; &nbsp;other &nbsp; &nbsp;non-rheumatoid &nbsp; &nbsp;(seronegative)&nbsp;arthropathies.</p><p>In &nbsp; the &nbsp; treatment &nbsp; of &nbsp; non-articular &nbsp; rheumatic &nbsp; conditions, &nbsp; Jazofen &nbsp; is &nbsp; indicated &nbsp; in&nbsp; periarticular &nbsp; conditions &nbsp; such &nbsp; as &nbsp; frozen &nbsp; shoulder &nbsp; (capsulitis), &nbsp; bursitis,&nbsp; &nbsp; tendonitis, tenosynovitis and low back pain; Jazofen can also be used in soft tissue injuries such&nbsp; as sprains and strains.</p><p>Jazofen &nbsp;is &nbsp;also &nbsp;indicated &nbsp;for &nbsp;its &nbsp;analgesic &nbsp;effect &nbsp;in &nbsp;the &nbsp;relief &nbsp;of &nbsp;mild &nbsp;to &nbsp;moderate&nbsp; &nbsp;pain such &nbsp;as dysmenorrhoea, dental &nbsp;and post-operative &nbsp;pain &nbsp;and &nbsp;for &nbsp;symptomatic relief &nbsp;of headache, including migraine headache.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(See Section 5.2 Pharmacokinetic properties-special patient population)</p><p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (See Section 4.4. Special warnings and precautions for use).</p><ul><li>Adults</li></ul><p>The recommended dosage of Jazofen is 1200 to 1800 mg daily in divided doses. Some patients can be maintained on 600 to 1200 mg daily. In severe or acute conditions, it can be advantageous to increase the dosage until the acute phase is brought under control, provided that the total daily dose does not exceed 2400 mg in divided doses.</p><ul><li>Children</li></ul><p>The daily dosage of Jazofen is 20 mg/kg of body weight in divided doses.</p><p>In Juvenile Rheumatoid Arthritis, up to 40 mg/kg of body weight daily in divided doses may be taken.</p><ul><li>Special patients population</li></ul><p>-&nbsp;&nbsp; Pediatric patients weighing less than 7 kg: Not recommended for children weighing less than 7 kg.</p><p>-&nbsp;&nbsp;&nbsp;Elderly: The elderly are at increased risk of serious consequences of adverse reactions. If a non-steroidal anti-inflammatory drug (NSAID) is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for gastrointestinal (GI) bleeding during NSAID therapy. If renal or hepatic function is impaired, dosage should be assessed individually.</p><p>For oral administration. To be taken preferably with or after food, with a glass of water. Jazofen tablets should be swallowed whole and not chewed, broken, crushed or sucked on to avoid oral discomfort and throat irritation.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazofen is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients.
Jazofen should not be used in patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria, angioedema or rhinitis) after taking ibuprofen, aspirin or other NSAIDs.
Jazofen is also contraindicated in patients with a history of gastrointestinal bleeding or perforation, related to previous NSAID therapy. Jazofen should not be used in patients with active, or history of, recurrent peptic ulcer or gastrointestinal haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
Jazofen should not be given to patients with conditions involving an increased tendency to bleeding.
Jazofen is contraindicated in patients with severe heart failure, hepatic failure and renal failure (See Section 4.4. Special warnings and precautions for use).

Jazofen is contraindicated during the last trimester of pregnancy (See Section 4.6. Pregnancy and lactation).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (See Section 4.2. Posology and method of administration).</p><p>Patients with rare hereditary problems of galactose intolerance, the Lapp lactose deficiency or glucose-galactose malabsorption should not take this medication.</p><p>As with other NSAIDs, ibuprofen may mask the signs of infection.</p><p>The use of Jazofen with concomitant NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to the increased risk of ulceration or bleeding (See Section 4.5. Interactions with other medicines products and other forms on interactions).</p><ul><li>Elderly</li></ul><p>The elderly have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal (See Section 4.2. Posology and method of administration).</p><ul><li>Gastrointestinal bleeding, ulceration and perforation</li></ul><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in&nbsp; patients with&nbsp; a history of&nbsp; ulcer,&nbsp; particularly if&nbsp; complicated&nbsp; with haemorrhage or perforation (See Section 4.3. Contraindications), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (See Section 4.5. Interactions with other medicinal products and other forms of interactions).</p><p>Patients with a history of gastrointestinal disease, particularly when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) particularly in the initial stages of treatment.</p><p>Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet agents such as aspirin (See Section 4.5. Interactions with other medicinal products and other forms of interactions).</p><p>When GI bleeding or ulceration occurs in patients receiving Jazofen, the treatment should be withdrawn.</p><p>NSAIDs should be given with care to patients with a history of ulcerative colitis or Crohn&#39;s disease as these conditions may be exacerbated (See Section 4.8. Undesirable effects).</p><ul><li>Respiratory disorders</li></ul><p>Caution is required if Jazofen is administered&nbsp; to patients suffering from, or with&nbsp; a previous history of, bronchial asthma since NSAIDs have been reported to precipitate bronchospasm in such patients.</p><ul><li>Cardiovascular, renal and hepatic impairment</li></ul><p>The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (See Section 4.3. Contraindications).</p><p>Jazofen should be given with care to patients with a history of heart failure or hypertension since edema has been reported in association with ibuprofen administration.</p><ul><li>Cardiovascular and cerebrovascular effects</li></ul><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and edema have been reported in association with NSAID therapy.</p><p>Epidemiological data suggest that use of ibuprofen, particularly at a high dose (2400 mg/ daily) and in long term treatment, may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke. Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. &le; 1200mg daily) is associated with an increased risk of arterial thrombotic events, particularly myocardial infarction.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><ul><li>Renal effects</li></ul><p>Caution should be used when initiating treatment with ibuprofen in patients with considerable dehydration.</p><p>As with other NSAIDs, long-term administration of ibuprofen has resulted in renal papillary necrosis and other renal pathologic changes. Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of an NSAID may cause a dose- dependent reduction in prostaglandin formation and, secondarily, in renal blood flow, which&nbsp; may precipitate overt&nbsp; renal decompensation. Patients at greatest&nbsp; risk of this reaction are those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors and the elderly. Discontinuation of NSAID therapy is usually followed by recovery to the pre-treatment state.</p><ul><li>SLE and mixed connective tissue disease</li></ul><p>In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis (See Section 4.8. Undesirable effects).</p><ul><li>Dermatological effects</li></ul><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens- Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (See Section 4.8. Undesirable effects). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring within the first month of treatment in the majority of cases. Jazofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><ul><li>Haematological effects</li></ul><p>Ibuprofen, like other NSAIDs, can interfere with platelet aggregation and has been shown to prolong bleeding time in normal subjects.</p><ul><li>Aseptic meningitis</li></ul><p>Aseptic meningitis has been observed on rare occasions in patients on ibuprofen therapy. Although it is probably more likely to occur in patients with systemic lupus erythematosus and related connective tissue diseases, it has been reported in patients who do not have an underlying chronic disease.</p><ul><li>Impaired female fertility</li></ul><p>The use of Jazofen may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of Jazofen should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Care should be taken in patients treated with any of the following drugs as interactions have been reported in some patients.</p><ul><li>Antihypertensives, beta-blockers and diuretics: NSAIDs may reduce the effect of anti- hypertensives, such as ACE inhibitors, beta-blockers and diuretics.</li><li>&nbsp; Diuretics can also increase the risk of nephrotoxicity of NSAIDs.</li><li>Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma cardiac glycoside levels.</li><li>Cholestyramine: The concomitant administration of ibuprofen and cholestyramine may reduce the absorption of ibuprofen in the gastrointestinal tract. However, the clinical significance is unknown.</li><li>Lithium: Decreased elimination of lithium.</li><li>Methotrexate: NSAIDs may inhibit the tubular secretion of methotrexate and reduce clearance of methotrexate.</li><li>Ciclosporin: Increased risk of nephrotoxicity.</li><li>Mifepristone: A decrease in the efficacy of the medicinal product can theoretically occur due to the antiprostaglandin properties of NSAIDs. Limited evidence suggests that coadministration of NSAIDs on the day of prostaglandin administration does not adversely influence the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of medicinal termination of pregnancy.</li><li>Other analgesics and cyclooxygenase-2 selective inhibitors: Avoid concomitant use of two or more NSAIDs, including Cox-2 inhibitors, as this may increase the risk of adverse effects (See Section 4.4. Special warnings and precautions for use).</li><li>Aspirin: As with other products containing NSAIDs, concomitant administration of ibuprofen and aspirin is not generally recommended because of the potential of increased adverse effects.</li></ul><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional use (See Section 5.1. Pharmacodynamics properties).</p><ul><li>Corticosteroids: Increased risk of gastrointestinal ulceration or bleeding with NSAIDs (See Section 4.4. Special warnings and precautions for use).</li><li>Anticoagulants: NSAIDs may enhance the effects of anticoagulants, such as warfarin (See Section 4.4. Special warnings and precautions for use).</li><li>Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions.</li><li>Sulfonylureas: NSAIDs may potentiate the effects of sulfonylurea medications. There have been rare reports of hypoglycaemia in patients on sulfonylurea medications receiving ibuprofen.</li><li>Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): Increased risk of gastrointestinal bleeding with NSAIDs (See Section 4.4. Special warnings and precautions for use).</li><li>Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.</li><li>Zidovudine: Increased risk&nbsp; of haematological toxicity when NSAIDs are&nbsp; given with zidovudine. There is evidence of an increased risk of haemarthroses and haematoma in HIV(+) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.</li><li>Aminoglycosides: NSAIDs may decrease the excretion of aminoglycosides.</li><li>Herbal extracts: Ginkgo biloba may potentiate the risk of bleeding with NSAIDs.</li><li>CYP2C9 Inhibitors: Concomitant administration of ibuprofen with CYP2C9 inhibitors may increase the exposure to ibuprofen (CYP2C9 substrate). In a study with voriconazole and fluconazole (CYP2C9 inhibitors), an increased S(+)-ibuprofen exposure by approximately 80 to 100% has been shown. Reduction of the ibuprofen dose should be considered when potent CYP2C9 inhibitors are administered concomitantly, particularly when high-dose ibuprofen is administered with either voriconazole or fluconazole.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Pregnancy</li></ul><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after the use of a prostaglandin synthesis inhibitor in early pregnancy. In animals, the administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post- implantation losses and embryo/foetal lethality. In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period.</p><p>During the first and second trimester of pregnancy, Jazofen should not be given unless clearly necessary. If Jazofen is used by a woman attempting to conceive, or during the first or second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the foetus to the following:</p><p>-&nbsp;&nbsp;Cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</p><p>-&nbsp;&nbsp;Renal dysfunction, which may progress to renal failure with oligohydramnios.</p><p>At the end of pregnancy, prostaglandin synthesis inhibitors may expose the mother and the neonate to the following:</p><p>-&nbsp;&nbsp;Possible prolongation of bleeding time;</p><p>-&nbsp;&nbsp;Inhibition of uterine contractions, which may result in delayed or prolonged labour.</p><p>&nbsp; Consequently, Jazofen is contraindicated during the third trimester of pregnancy.</p><ul><li>Lactation</li></ul><p>In the limited studies so far available, NSAIDs can appear in the breast milk in very low concentrations. NSAIDs should, if possible, be avoided when breastfeeding.</p><ul><li>Fertility:&nbsp; See section 4.4 Special warnings and precautions for use, regarding female fertility.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects such as dizziness, drowsiness, fatigue and visual disturbances are possible after taking NSAIDs. If affected, patients should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>The most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI bleeding, sometimes fatal, particularly in the elderly, may occur (See Section 4.4. Special warnings and precautions for use). Nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn&#39;s disease (See Section 4.4. Special warnings and precautions for use) have been reported following ibuprofen administration. Less frequently, gastritis has been observed. Gastrointestinal perforation has been rarely reported with ibuprofen use. Pancreatitis has also been reported very rarely.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of (a) non-specific allergic reaction and anaphylaxis, (b) respiratory tract reactivity comprising asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura, angioedema and, more rarely, exfoliative and bullous dermatoses (including Stevens- Johnson syndrome, toxic epidermal necrolysis and erythema multiforme).</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac disorders and vascular disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Edema, hypertension and cardiac failure have been reported in association with NSAID treatment. Epidemiological data suggest that use of ibuprofen, particularly at high dose (2400 mg/ daily), and in long term treatment, may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke (See Section 4.4. Special warnings and precautions for use)<em>.</em></p><p>Other adverse events reported less commonly and for which causality has not necessarily been established include.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Leukopenia, thrombocytopenia, neutropenia, agranulocytosis, aplastic anemia and haemolytic anemia.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Insomnia, anxiety, depression, confusional state, hallucination.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Optic neuritis, headache, paraesthesia, dizziness, somnolence.</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rhinitis and aseptic meningitis (especially in patients with existing autoimmune disorders, such as systemic lupus erythematosus and mixed connective tissue disease) with symptoms of stiff neck, headache, nausea, vomiting, fever or disorientation (See Section 4.4. Special warnings and precautions for use).</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Visual impairment and toxic optic neuropathy.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hearing impaired, tinnitus and vertigo.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Abnormal liver function, hepatic failure, hepatitis and jaundice.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Bullous reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis (very rare), and photosensitivity reaction.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Impaired renal function and toxic nephropathy in various forms, including interstitial nephritis, nephrotic syndrome and renal failure.</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Malaise, fatigue.</p></td></tr></tbody></table><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Toxicity</li></ul><p>Signs and symptoms of toxicity have generally not been observed at doses below 100 mg/kg in children or adults. However, supportive care may be needed in some cases. Children have been observed to manifest signs and symptoms of toxicity after ingestion of 400 mg/kg or greater.</p><ul><li>Symptoms</li></ul><p>Most patients who have ingested significant amounts of ibuprofen will manifest symptoms within 4 to 6 hours.</p><p>The most frequently reported symptoms of overdose include nausea, vomiting, abdominal pain, lethargy and drowsiness. Central nervous system (CNS) effects include headache, tinnitus, dizziness, convulsion, and loss of consciousness. Nystagmus, metabolic acidosis, hypothermia, renal effects, gastrointestinal bleeding, coma, apnoea, diarrhea and depression of the CNS and respiratory system have also been rarely reported. Disorientation, excitation, fainting and cardiovascular toxicity, including hypotension, bradycardia and tachycardia have been reported. In cases of significant overdose, renal failure and liver damage are possible. Large overdoses are generally well tolerated when no other drugs are being taken.</p><ul><li>Therapeutic measures</li></ul><p>Patients should be treated symptomatically as required. Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered. Alternatively, in adults, gastric lavage should be considered within one hour of ingestion of a potentially life-threatening overdose.</p><p>Good urine output should be ensured.</p><p>Renal and liver function should be closely monitored.</p><p>Patients should be observed for at least four hours after ingestion of potentially toxic amounts.</p><p>Frequent or prolonged convulsions should be treated with intravenous diazepam. Other measures may be indicated by the patient&#39;s clinical condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Non-steriodal anti-inflammatory drug. ATC code: M01AE01</p><p>Ibuprofen is a propionic acid derivative with analgesic, anti-inflammatory and anti- pyretic activity. The drug&#39;s therapeutic effects as an NSAID is thought to result from its inhibitory effect on the enzyme cyclo-oxygenase, which results in a marked reduction in prostaglandin synthesis.</p><p>Experimental data suggest that ibuprofen may inhibit the effect of low dose aspirin on platelet aggregation when they are dosed concomitantly. In one study, when a single dose of ibuprofen 400mg was taken within 8 hours before or within 30 minutes after immediate release aspirin dosing (81mg), a decreased effect of aspirin on the formation of thromboxane or platelet aggregation occurred. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ibuprofen is rapidly absorbed from the gastrointestinal tract, peak serum concentrations occurring 1 to 2 hours after administration. The elimination half-life is approximately 2 hours.</p><p>Ibuprofen is metabolized in the liver to two inactive metabolites and these, together with unchanged ibuprofen, are excreted by the kidney either as such or as conjugates. Excretion by the kidney is both rapid and complete.</p><p>Ibuprofen is extensively bound to plasma proteins.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- &nbsp;Povidone K-30;<br />- &nbsp;Sodium lauryl sulphate;<br />- &nbsp;Microcrystalline cellulose;<br />- &nbsp;Croscarmellose sodium;<br />- &nbsp;Colloidal silicon dioxide;<br />- &nbsp;Magnesium sterate;<br />- &nbsp;Alcohol;<br />- &nbsp;Talc;<br />- &nbsp;Titanium dioxide;<br />- &nbsp;Polyethylene glycol;<br />- &nbsp;Hypermellose;<br />- &nbsp;Simethicone emulsion;<br />- &nbsp;Erythrocin FD&amp;C red No. 3;<br />- &nbsp;Polyacrylate dispersion 30.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister of 30 tablets per pack.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Jiser Heet, after Third Industrial Zone
Riyadh-Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                28 March 2013
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>